Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia.
about
X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17Comparative transcriptomics and metabolomics in a rhesus macaque drug administration study.Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.
P2860
Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia.
@en
type
label
Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia.
@en
prefLabel
Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia.
@en
P2860
P1476
Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia.
@en
P2093
Courtney D DiNardo
P2860
P304
P356
10.1517/13543784.2014.864276
P407
P577
2013-12-09T00:00:00Z